Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

The new prices were made possible by the Medicare negotiation program created under the Biden administration's Inflation ...

The Centers for Medicare & Medicaid Services (CMS) said newly negotiated lower prices for 15 drugs will save 44%, or $12 billion, from last year’s negotiated Medicare spending. The drugs, widely used ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product in the talks since they all share the ...

The Biden administration this week released the first 10 drugs that will be subject to those talks, a process that aims to lower the prices of medications that Medicare Part D spends the most on. The ...

A deal between President Donald Trump and Novo Nordisk A/S to slash Ozempic and Wegovy prices under a most-favored-nation ...

The Centers for Medicare and Medicaid Services announced that prices for 15 prescription drugs, including Ozempic, would be ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

Government health officials announced on Tuesday that Medicare recipients will soon pay less for 15 prescription drugs, ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.